Pharmabiz9m
Novo Nordisk announces positive results from phase 3 ESSENCE trial of semaglutide 2.4 mg to treat adults with MASH and liver fibrosis
Bagsværd, Denmark Tuesday, November 5, 2024, 10:00 Hrs [IST] ...
Pharmabiz1h
HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA-editing HG202 for macular degeneration
HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...
Pharmabiz2h
PLI & Ayushman Bharat initiatives will transform Indian pharma & healthcare sectors: Anil Matai
PLI & Ayushman Bharat initiatives will transform Indian pharma & healthcare sectors: Anil Matai: Nandita Vijayasimha, Bengaluru Tuesday, November 5, 2024, 08:00 Hrs [IST] The Dire ...
Pharmabiz2h
DHR invites applications for 2024-25 fellowships abroad
The Department of Health Research (DHR) under the ministry of health & family welfare, Government of India, is calling for applications from Indian scientists for short-term and long-term ...
Pharmabiz2h
DGTR launches anti-dumping probe on calcium carbonate filler masterbatch imports from Vietnam
DGTR launches anti-dumping probe on calcium carbonate filler masterbatch imports from Vietnam: Shardul Nautiyal, Mumbai Tuesday, November 5, 2024, 08:00 Hrs [IST] India’s Direct ...
Pharmabiz2h
DoP upholds ceiling price fixation for auto-immune disease drug azathioprine 50 mg
DoP upholds ceiling price fixation for auto-immune disease drug azathioprine 50 mg: Gireesh Babu, New Delhi Tuesday, November 5, 2024, 08:00 Hrs [IST] The Department of Pharmaceut ...
Pharmabiz18h
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab
Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...
Pharmabiz18h
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant: Rockville, Maryland Monday, November 4, 2024, 16:00 Hrs [IST] Ther ...
Pharmabiz16h
NIH study demonstrates long-term benefits of weight-loss surgery in young people
NIH study demonstrates long-term benefits of weight-loss surgery in young people: Bethesda, Maryland Monday, November 4, 2024, 18:00 Hrs [IST] Young people with severe obesity who ...
Pharmabiz20h
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer: Boston Monday, November 4, 2024, 14:00 Hrs ...
Pharmabiz17h
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...
Pharmabiz19h
BioRestorative Therapies’ ThermoStem metabolic disease programme receives Israeli patent
BioRestorative Therapies’ ThermoStem metabolic disease programme receives Israeli patent: Melville, New York Monday, November 4, 2024, 15:00 Hrs [IST] BioRestorative Therapies, ...